Evidence map›Paper›PMID 30963657›Full record

ArticlePlant biotechnology journal2019

Validation of leaf and microbial pectinases: commercial launching of a new platform technology.

Henry Daniell, Thuanne Ribeiro, Shina Lin, Prasenjit Saha, Colleen McMichael, Rashmi Chowdhary, Anshika Agarwal

Open access · goldAbstract read
In one paragraph

Article in Plant biotechnology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Plastid engineering using episomal DNA.Plant cell reports · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Mini-synplastomes for plastid genetic engineering.Plant biotechnology journal · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Henry DaniellDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0003-4485-1176
Thuanne RibeiroDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Shina LinDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Prasenjit SahaDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Colleen McMichaelPhyllozyme, Pennovation Center, Philadelphia, PA, USA.
Rashmi ChowdharyDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Anshika AgarwalDepartment of Biochemistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · US

Funding

Oral immune modulatory therapy using antigens bioencapsulated in plant cellsR01HL107904 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DANIELL, HENRY · 2011 to 2023
$7.5M
Oral Therapy for Hemophilia AR01HL109442 · NHLBI · UNIVERSITY OF FLORIDA · PI DANIELL, HENRY, HERZOG, ROLAND W. · 2011 to 2015
$3.5M
Oral Tolerance for HemophiliaR01HL133191 · NHLBI · UNIVERSITY OF FLORIDA · PI DANIELL, HENRY, HERZOG, ROLAND W. · 2017 to 2020
$2.8M
Oral therapy for diabetic retinopathy using ACE2/Ang1-7 bioencapsulated in plant cellsR01EY024564 · NEI · UNIVERSITY OF FLORIDA · PI DANIELL, HENRY, LI, QIUHONG · 2015 to 2018
$1.6M
NEI NIH HHS R01 EY024564NHLBI NIH HHS R01 HL107904NHLBI NIH HHS R01 HL109442NHLBI NIH HHS R01 HL133191NIH HHS EY 024564, HL 107904, 109442, HL 133191
6 · The paper itself

Abstract

Almost all current genetically modified plant commercial products are derived from seeds. The first protein product made in leaves for commercial use is reported here. Leaf pectinases are validated here with eight liquid commercial microbial enzyme products for textile or juice industry applications. Leaf pectinases are functional in broad pH/temperature ranges as crude leaf extracts, while most commercial enzyme products showed significant loss at alkaline pH or higher temperature, essential for various textile applications. In contrast to commercial liquid enzymes requiring cold storage/transportation, leaf pectinase powder was stored up to 16 months at ambient temperature without loss of enzyme activity. Commercial pectinase products showed much higher enzyme protein PAGE than crude leaf extracts with comparable enzyme activity without protease inhibitors. Natural cotton fibre does not absorb water due to hydrophobic nature of waxes and pectins. After bioscouring with pectinase, measurement of contact-angle water droplet absorption by the FAMAS videos showed 33 or 63 (leaf pectinase), 61 or 64 (commercial pectinase) milliseconds, well below the 10-second industry requirements. First marker-free lettuce plants expressing pectinases were also created by removal of the antibiotic resistance aadA gene. Leaf pectinase powder efficiently clarified orange juice pulp similar to several microbial enzyme products. Commercial pilot scale biomass production of tobacco leaves expressing different pectinases showed that hydroponic growth at Fraunhofer yielded 10 times lower leaf biomass per plant than soil-grown plants in the greenhouse. Pectinase enzyme yield from the greenhouse plants was double that of Fraunhofer. Thus, this leaf-production platform offers a novel, low-cost approach for enzyme production by elimination of fermentation, purification, concentration, formulation and cold chain.

Indexed as

Plant LeavesPolygalacturonaseBiomassBiotechnologyFermentationLactucaPectinsTemperaturePectinsPolygalacturonaseambient storagebioscouringchloroplast enzymesfruit juicepectinasestabilitytextile

Identifiers

PMID30963657
PMCPMC6523602
OpenAlexW2937949018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.